- CA$14.01m
- CA$14.42m
- CA$4.11m
- 47
- 46
- 64
- 51
Annual income statement for Reklaim, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.028 | 0.178 | 1 | 2.36 | 4.11 |
Cost of Revenue | |||||
Gross Profit | 0.018 | -0.214 | -0.439 | -0.131 | 3.18 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.89 | 4.51 | 7.33 | 6.55 | 3.2 |
Operating Profit | -6.87 | -4.33 | -6.33 | -4.19 | 0.91 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.87 | -4.33 | -6.32 | -4.19 | 0.91 |
Net Income After Taxes | -6.87 | -4.33 | -6.32 | -4.19 | 0.91 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -9.06 | -4.65 | -6.32 | -4.19 | 0.91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.06 | -4.65 | -6.32 | -4.19 | 0.91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.132 | -0.1 | -0.106 | -0.058 | 0.004 |